Brain health

Cognition + homocysteine

~30% tHcy drop

Brain atrophy −40%

Brain chemistry +memory

−15 pp vasospasm

Brain volumes +cognition

Brain inflammation/stress ↓

Cognition/behavior ↑

Phe/DA brain effects

Phe lowering in PKU

Brain networks +0.015

+4 IQ / +7 MDI

Memory/attention + DHA

Memory/cognition +

Homocysteine ↓

Cognition + memory

+1.95 points

MS/PD lesion control

AA/DHA boosts brain growth

+7 MDI; visual gains

AA/DHA balance matters

Cognition +3.5%

Memory/behavior +25%

Brain oxidative/memory

Brain decline/lesions

Cognition +5–15%

Brain lipids/choline ↑

Attention/memory +

Improved dementia ratings

Boosted blood flow

Cognition/neurology improved

Ischemia reduced ~25%

NAD+ up, symptoms down

Cognition + memory

Addiction cravings −30%

Inflammation/brain markers

DHA/omega-3 status

Cognition/motor gains

Less migraine/MS risk

Cognition +3.5%

Function/mood preserved

Dementia risk -18%

Brain signals + cognition

+5.4 memory, +0.89 FC

-1β, +BDNF

Migraine relief: −1.8 days

Stroke recovery: −25% lesion

Cognition/fatigue: improved scores

Memory + cognition

EEG/glucose metabolism

Fatty acids/neurotransmitters

Memory/executive +0.84

+ methylation/choline

Depression response +18.5%

Cognition/blood flow

Inflammation/neuronal protection

Brain metabolism +NAA/Cho

Gray matter + visual

Stroke/head injury outcomes

Brain function +29%

Neurotransmitters/EEG changes

Brain speed +17.7%

Memory preservation

Executive gains

Cognition + working memory

ASD/ADHD symptoms -34%

Schizophrenia negative symptoms d≈0.8

Cognition + stroke recovery

Blood flow + inflammation

Brain markers + symptoms

Depression benefit +19%

Schizophrenia symptoms −19%

Memory/attention up

ADAS cognition improved

Methylation/cognition: −36% Hcy

Choline/betaine brain support

Better brain recovery

Reduced injury markers

Clotting ↑, hemorrhage ↓

PIVH -20.8%

Clotting ↑, hemorrhage ↓

Neuropathy ↓; OR 0.62

Motor signs/tremor ↑

AIMS response +46.2%

Auditory plasticity/MMN ↑

Symptoms/cognition: +10%, −4%

Better memory, cognition

MoCA +3.7; mortality -24%

Blood flow/oxygenation ↑

Attention/mood slightly better

Cognition/markers improved

Cognition/ADL +4.6

Memory/behavior +58%

Neuroprotection, less inflammation

ALS decline slowed +0.42/month

Survival +6.5 months

Memory +BP lower

Oxygenation + mood

Amyloid/cognition +42

Neurological recovery faster

Cognition stabilized +2.1

Cognition + attention

Fall risk -

MDA -14%

Executive function +21 s

Oxidative stress −65 pg/mL

IQ +4.1

DHA rises

↑BDNF, ↓cortisol, cognition

+21% BDNF; ↓depression

Attention/speed +

Memory/function +

Memory/behavior +3.7

Choline/memory +2.4

Psych symptoms ↓

Cognition decline ↓

Cognition + BDNF

Depression risk -9.6%

Lutein +25%; cognition

Attention up; MPD up

Executive +0.30

Motor -3.3

Omega-3 absorption 3x

Memory + neurogenesis

-

Cognition + memory

Migraine inflammation ↓

Mood, anxiety ↑

Cognition +29%

Brain metabolism/NAD+

Hippocampal structure preserved

Cognition +3.1

Inflammation/oxidative stress -

Reaction time improved

CBF trend only

ALS function +

strength, lung function +

muscle/fat ratio +